Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Kansas City, Missouri 64111


Purpose:

The primary purpose of this study is to determine the best dose of tezacitabine when combined with oxaliplatin in patients with metastatic colorectal cancer. This study will also evaluate tumor response to the combination of anti-cancer drugs.


Criteria:

- Patients with metastatic colorectal adenocarcinoma who have failed one prior course of chemotherapy. - Patients must have at least one measurable tumor. - Patients may not have received prior treatment with oxaliplatin.


NCT ID:

NCT00051688


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Kansas City, Missouri 64111
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.